Home » Topics » Conferences

Conferences
RSS

AMD-3100: a potent chemokine CXCR4 antagonist enters clinical testing

July 10, 1998

Anti-HIV peptide T-22 acts as a CXCR4 receptor antagonist

July 10, 1998

Enzo discovery paves the way for antisense therapy of AIDS

July 10, 1998

IL-4 fusion toxin shows potent antitumor activity in murine model of KS

July 10, 1998

New nonfeminizing estrogens with radical-scavenging activity

July 10, 1998

Clinical trial results in RA reported for T-614

July 9, 1998

Mechanism of action of new antiarthritic drug KE-298

July 9, 1998

MX-68: mechanisms underlying antiinflammatory activity

July 9, 1998

AMD-3465, a selective CXCR4 antagonist with potent anti-HIV activity

July 9, 1998

Lodenosine phase I data supports combination studies

July 9, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...